290
Participants
Start Date
November 5, 2019
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Metformin Hydrochloride
"The intervention will consist in IMP treatment during 30 months with half of the patients treated with Metformin Glucophage SR. Tablets of 500mg will be used at a dose of 2x500mg preferably taken during the evening meal.~During the first month of the trial a dose of 1x500mg will be used in order to avoid as much as possible some well-known mainly gastrointestinal side effects of metformin treatment ."
Placebo Oral Tablet
The intervention will consist in IMP treatment during 30 months with half of the patients treated with matched placebo. Tablets of 500mg will be used at a dose of 2x500mg preferably taken during the evening meal.
AZ Delta, Roeselare
OLVZ Aalst, Aalst
Epicura Ath, Ath
Epicura Baudour, Baudour
Imelda Ziekenhuis Bonheiden, Bonheiden
CHU Brugmann, Brussels
Hôpital Erasme, Brussels
UZ Brussel, Brussels
Grand Hôpital de Charleroi, Charleroi
Antwerp University Hospital, Edegem
Ghent University Hospital, Ghent
Jessa Ziekenhuis, Hasselt
Centre Hospitalier Régional de la Citadelle, Liège
Centre Hospitalier Universitaire Liège (CHU Liège), Liège
Centre Hospitalier Régional de Namur, Namur
AZ Nikolaas, Sint-Niklaas
Centre Hospitalier de Wallonie Picarde, Tournai
AZ Turnhout, Turnhout
CHR Verviers, Verviers
University Hospital, Antwerp
OTHER
Universiteit Antwerpen
OTHER